ProfileGDS4718 / 231991_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 62% 59% 66% 60% 64% 49% 55% 59% 62% 63% 64% 66% 56% 52% 55% 60% 63% 60% 57% 72% 62% 60% 61% 68% 61% 59% 63% 54% 63% 58% 48% 57% 63% 59% 58% 60% 56% 63% 61% 77% 62% 54% 68% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.2452262
GSM549102patient 115, normal, homogenized [OPG study]6.0640959
GSM549104patient 119, normal, homogenized [OPG study]6.6106866
GSM549108patient 138, normal, homogenized [OPG study]6.1725160
GSM549119patient 077, normal, homogenized [OPG study]6.3917164
GSM549133patient 032, cancer, homogenized [OPG study]5.4166349
GSM549139patient 042, cancer, homogenized [OPG study]5.7616755
GSM549099patient 107, normal, homogenized [OPG study]6.0377259
GSM549109patient 139, normal, homogenized [OPG study]6.2748762
GSM549110patient 046, normal, homogenized [OPG study]6.3263
GSM549114patient 063, normal, homogenized [OPG study]6.3744764
GSM549122patient 082, normal, homogenized [OPG study]6.5849866
GSM549134patient 033, cancer, homogenized [OPG study]5.852956
GSM549136patient 036, cancer, homogenized [OPG study]5.5751352
GSM549140patient 044, cancer, homogenized [OPG study]5.7578355
GSM549111patient 047, normal, homogenized [OPG study]6.0986560
GSM549113patient 057, normal, homogenized [OPG study]6.3220663
GSM549132patient 031, cancer, homogenized [OPG study]6.1016260
GSM549137patient 038, cancer, homogenized [OPG study]5.9097957
GSM549142patient 047, cancer, homogenized [OPG study]6.9747972
GSM549100patient 110, normal, homogenized [OPG study]6.2681362
GSM549107patient 135, normal, homogenized [OPG study]6.0966760
GSM549115patient 068, normal, homogenized [OPG study]6.1413461
GSM549116patient 072, normal, homogenized [OPG study]6.7171568
GSM549120patient 078, normal, homogenized [OPG study]6.1877361
GSM549131patient 030, cancer, homogenized [OPG study]6.050659
GSM549118patient 074, normal, homogenized [OPG study]6.3735263
GSM549129patient 027, cancer, homogenized [OPG study]5.7912954
GSM549123patient 088, normal, homogenized [OPG study]6.3370763
GSM549124patient 006, cancer, homogenized [OPG study]5.9955958
GSM549126patient 015, cancer, homogenized [OPG study]5.3648248
GSM549128patient 025, cancer, homogenized [OPG study]5.927657
GSM549103patient 117, normal, homogenized [OPG study]6.3624863
GSM549117patient 073, normal, homogenized [OPG study]5.9922259
GSM549138patient 041, cancer, homogenized [OPG study]5.9760258
GSM549141patient 045, cancer, homogenized [OPG study]6.1220760
GSM549130patient 028, cancer, homogenized [OPG study]5.8694956
GSM549101patient 111, normal, homogenized [OPG study]6.349563
GSM549105patient 128, normal, homogenized [OPG study]6.1730261
GSM549106patient 134, normal, homogenized [OPG study]7.6500177
GSM549112patient 048, normal, homogenized [OPG study]6.2191862
GSM549125patient 011, cancer, homogenized [OPG study]5.7213254
GSM549127patient 024, cancer, homogenized [OPG study]6.7615368
GSM549135patient 035, cancer, homogenized [OPG study]5.7943555